Posted in | News | Nanoenergy

Installation of Thin-Film Modules at Chevron's Solar Energy Facility in California

MiaSole, a leading manufacturer of Copper Indium Gallium Selenide (CIGS) thin-film photovoltaic solar panels, today announced the installation of thin-film modules providing 200 kW of power at Project Brightfield, a 740KW solar energy demonstration facility owned by Chevron Corporation at their former refinery site near Bakersfield, California.

Project Brightfield brings together seven emerging solar photovoltaic companies for the testing and evaluation of 7,700 solar panels, making it one of the most comprehensive sites in the United States.  The site will measure the amount of energy produced by each solar technology and monitor how weather elements – such as temperature, rain, wind and humidity – affect the panels' performance.

"Solar energy is one of the most cost effective, efficient sources of energy on earth and we are pleased to be a part of a project that shows not only the power of solar energy, but also how efficient and reliable MiaSole's CIGS thin film solar technology is," said Joe Laia, CEO of MiaSole.

The project is a milestone for MiaSole, marking the company's first commercial project in California.

MiaSole's CIGS thin-film photovoltaic solar panels convert 10.5% of sunlight into electricity and have some of the highest efficiency rates for thin film solar technology in the world. The products are designed specifically for large-scale rooftop and ground mount installations for utilities, independent power providers and industrial scale deployments.

Source: http://www.neophotonics.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.